FOXO4-DRI is a modified peptide designed for research into cellular signalling mechanisms, particularly those involving transcription factors and regulatory protein interactions
HUBERMAN: To learn more about the supplements discussed on the Huberman Lab podcast, please go to LiveMomentous, spelled O-U-S
[1] [3] Topamax, on the other hand, is an antiepileptic drug (AED) primarily indicated for epilepsy and migraine prophylaxis
It is important to emphasise that these proposals are based almost entirely on preclinical data principally in vitro (cell culture) experiments and animal studies and have not been reliably demonstrated in robust human clinical trials: Stimulation of follicle enlargement: Laboratory studies suggest GHK-Cu may increase hair follicle size, potentially counteracting the miniaturisation associated with androgenetic alopecia (pattern hair loss), though this has not been confirmed in humans
P., Cristaldi, E., Colonna, V., Messano, M., Koverech, A., Neri, S., Vacante, M., Cammalleri, L., and Motta, M